Compare IMVT & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | LEVI |
|---|---|---|
| Founded | 2018 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.1B |
| IPO Year | 2019 | 2019 |
| Metric | IMVT | LEVI |
|---|---|---|
| Price | $28.12 | $21.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $48.88 | $26.79 |
| AVG Volume (30 Days) | 1.3M | ★ 4.5M |
| Earning Date | 11-09-2026 | 10-07-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | N/A | ★ 178.85 |
| EPS | N/A | ★ 1.10 |
| Revenue | N/A | ★ $6,282,000,000.00 |
| Revenue This Year | N/A | $7.26 |
| Revenue Next Year | N/A | $4.59 |
| P/E Ratio | ★ N/A | $19.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.05 | $17.72 |
| 52 Week High | $45.42 | $25.70 |
| Indicator | IMVT | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 30.46 | 65.70 |
| Support Level | $25.83 | $20.60 |
| Resistance Level | $29.83 | $23.56 |
| Average True Range (ATR) | 1.15 | 0.63 |
| MACD | 0.19 | 0.27 |
| Stochastic Oscillator | 28.03 | 99.42 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.